SBIR/STTR Research Award
ORGANIC PHASE IMMUNOCHEMISTRY
Award amount
$50,000Program and phase
SBIR · Phase IAward year
1989Award details
- Awarding agency
- National Science Foundation
- Branch
- Not reported
- Recipient company
- HAWAII BIOTECH, INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- ECJKEEFL4L51
- Solicitation number
- Not reported
- Topic code
- Not reported
Research abstract
IMMUNOCHEMICAL TECHNIQUES HAVE MANY DIVERSE APPLICATIONS. HOWEVER, THEY ARE RESTRICTED TO USE ONLY IN AQUEOUS MEDIA. ECONOMICAL TECHNIQUES FOR DIRECT ORGANIC PHASE ANALYSIS AND IMMUNOAFFINITY ISOLATION WOULD SIGNIFICANTLY BROADEN THE USEFULNESS OF ANTIBODY-BASED TECHNOLOGY. THE PURPOSE OF THIS PROJECT IS TO DETERMINE THE FEASIBILITY OF EXPLOITING ANTIGEN-ANTIBODY BINDING IN THE ORGANIC PHASE. A SERIES OF SOLVENTS, ANTIBODIES, AND ANTIGENS WILL BE SELECTED TO IDENTIFY THE PARAMETERS INFLUENCING ANTIGEN-ANTIBODY BINDINGIN SOLVENT. DETECTABLE SPECIFIC BINDING WILL BE THE BASIS FOR JUSTIFYING DEVELOPMENT OF ORGANIC PHASE IMMUNOASSAYS, AFFINITY ISOLATION TECHNIQUES, AND OTHER NOVEL APPLICATIONS FOR ANTIBODIES.
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Chikungunya Recombinant Subunit Vaccine
- Development of a Cross-Protective New World Encephalitic Alphavirus Subunit Vaccine
- Novel TLR-4 Agonists as Vaccine Adjuvants
- RECOMBINANT WEST NILE VIRUS VACCINE ADJUVANTED WITH SLA-LSQ
- Chikungunya Recombinant Subunit Vaccine
Research funding history
103 SBIR/STTR records share this UEI (1983–2024). Reported award amounts total $40,917,853. Reported amounts are not federal obligations.
Phases: Phase I, Phase II, Phase II – Direct to Phase II
Agencies: Department of Health and Human Services, Department of Defense, National Science Foundation, Department of Agriculture